Tacrolimus or infliximab for severe ulcerative colitis: short-term and long-term data from a retrospective observational study

Abstract

ObjectiveTreatment of severe ulcerative colitis (UC) is challenging. Although the efficacy of tacrolimus (TAC) and infliximab (IFX) have been evaluated in patients with severe UC, the safety and efficacy levels...